177Lu-DOTA-AE105

has antineoplastic activity; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Colorectal Neoplasms (Colorectal Cancer) 10/01/2012 - "New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts."
2.	Neoplasms (Cancer) 10/01/2012 - "New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts."

1.	Peptide Receptors (Peptide Receptor)
2.	Radioisotopes (Radionuclides)

1.	Therapeutics